Bioavailability Study of K0706 in Healthy Subjects

Summary

This is single-center, single-dose, randomized, open-label, four-period, four sequence crossover study to evaluate the relative bioavailability of K0706 24 mg tablet formulation relative to 24 mg capsule formulation under fasted conditions and to evaluate the food-effect for tablet formulation in healthy subjects.

Timeline

Start

2017-10-28

Primary completion

2017-11-21

Completion

2017-11-21

Drugs

Indications

No indication recorded.